Home / Clinical Laboratory / Clinical Analyzer Calibrators and Reagents / Reagents / Reagent / Reagent Immulite® Cancer Prostate-specific Antigen (PSA) For the Immulite® / Immulite® 1000 Systems 100 Tests10706279
Picture of Reagent Immulite® Cancer Prostate-specific Antigen (PSA) For the Immulite® / Immulite® 1000 Systems 100 Tests10706279

Reagent Immulite® Cancer Prostate-specific Antigen (PSA) For the Immulite® / Immulite® 1000 Systems 100 Tests10706279

Reagent-Immulite®-Cancer-Prostate-specific-Antigen-(PSA)-For-the-Immulite®--Immulite®-1000-Systems-100-Tests10706279

SKU #

#863632

MPN #

10706279

Brand

Siemens

Stock

In Stock

Quantity

100

Features

REAGENT, IMMULITE PSA 1000 (100/BX) ALT# 10LKPTS1(D) D/S

$196.68 USD

Attribute Name Attribute Value
McKesson # 863632
Manufacturer # 10706279
Brand Immulite®
Manufacturer Siemens
Application Reagent
For Use With For the Immulite® / Immulite® 1000 Systems
Number of Tests 100 Tests
Sample Type Human Serum Sample
Storage Requirements Requires Refrigeration
Test Name Prostate-specific Antigen (PSA)
Test Type Cancer
Type Chemiluminescent Immunometric Assay
UNSPSC Code 41116004

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • For in vitro diagnostic use with the IMMULITE® and IMMULITE 1000 Analyzers - for the quantitative measurement of prostate-specific antigen detection of prostate cancer when used in conjunction with digital rectal examination (DRE) in men aged 50 years or older